| Deler fremragende | 8,878,582 shares |
| Insideraktier | 20.229.603 shares |
| Total Insiders | 16 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Minerva Surgical, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Accelmed Partners II L.P.
10% Owner -
|
122.189.638 | 6.109.482 | |
| Jill Anderson Director - [D] | 49.792 | 2.490 | |
| Ali Behbahani Director - [D] | 58.279 | 2.914 | |
| David M Clapper President and CEO, Director - [D] [O] | 323.232 | 16.162 | |
| Daniel Cohen Director - [D] | 122.189.638 | 6.109.482 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Catherine Coste Director - [D] | 129.579 | 6.479 | |
| Filloux Dominique J. COO - [O] | 266.289 | 13.314 | |
|
Uri Geiger
Director, 10% Owner -
[D]
|
122.189.638 | 6.109.482 | |
| Hunt Niquette L. Director - [D] | 49.792 | 2.490 | |
| Ross A Md Jaffe Director - [D] | 49.792 | 2.490 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Joel R Jung CFO - [O] | 220.730 | 11.036 | |
|
New Enterprise Associates 13 Lp
10% Owner -
|
34.437.052 | 1.721.853 | |
|
A/S Novo
10% Owner -
|
2.057.132 | 102.857 | |
| David Renzi Director - [D] | 49.792 | 2.490 | |
| Skalnyi Evgueni V. VP Medical Affairs - [O] | 244.725 | 12.236 | |
| Derrick Sung Director - [D] | 86.956 | 4.348 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i UTRS / Minerva Surgical, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i UTRS / Minerva Surgical, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-14 | 3 | Cohen Daniel | UTRS | Common Stock | I | 122.189.638 | ||||||||
| 2023-02-10 | 2023-02-09 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Common Stock | D | 0,2046 | 24.437.927 | 5.000 | 34.437.052 | ||||
| 2023-02-09 | 3 | Accelmed Partners II L.P. | UTRS | Common Stock | D | 122.189.638 | ||||||||
| 2023-02-09 | 3 | Geiger Uri | UTRS | Common Stock | I | 122.189.638 | ||||||||
| 2022-08-09 | 2022-05-02 | 4 | Jung Joel R | UTRS | Common Stock | D | 60.198 | 220.730 | ||||||
| 2022-08-09 | 2022-05-02 | 4 | Clapper David M | UTRS | Common Stock | D | 229.732 | 323.232 | ||||||
| 2022-08-09 | 2022-07-19 | 4 | Sung Derrick | UTRS | Common Stock | D | 2,3000 | 86.956 | 200 | 86.956 | ||||
| 2022-08-09 | 2022-05-02 | 4 | Filloux Dominique J. | UTRS | Common Stock | D | 60.198 | 266.289 | ||||||
| 2022-08-09 | 2022-05-02 | 4 | Skalnyi Evgueni V. | UTRS | Common Stock | D | 49.755 | 244.725 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | Behbahani Ali | UTRS | Common Stock | D | 2,4100 | 49.792 | 120 | 58.279 | ||||
| 2022-06-14 | 2022-06-10 | 4 | JAFFE ROSS A MD | UTRS | Common Stock | D | 2,4100 | 49.792 | 120 | 49.792 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Renzi David | UTRS | Common Stock | D | 2,4100 | 49.792 | 120 | 49.792 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Hunt Niquette L. | UTRS | Common Stock | D | 2,4100 | 49.792 | 120 | 49.792 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Coste Catherine | UTRS | Common Stock | D | 2,4100 | 49.792 | 120 | 129.579 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Anderson Jill | UTRS | Common Stock | D | 2,4100 | 49.792 | 120 | 49.792 | ||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -464 | 0 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -432 | 464 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -438 | 896 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -455 | 1.334 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -73.816 | 0 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -68.634 | 73.816 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -69.613 | 142.450 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -72.374 | 212.063 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 464 | 1.789 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 432 | 1.325 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 438 | 893 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 455 | 455 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 73.816 | 284.437 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 68.634 | 210.621 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 69.613 | 141.987 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 72.374 | 72.374 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -5.257 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -4.888 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -4.958 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -5.155 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -834.568 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -775.986 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -787.050 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -818.269 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -3.148 | 0 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -499.843 | 0 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series C Preferred Stock | I | -5.536 | 0 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series C Preferred Stock | I | -878.947 | 0 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Common Stock | I | 10.473 | 10.473 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Common Stock | I | 1.663.227 | 1.663.227 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -24.760 | 0 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -34.986 | 24.760 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -35.009 | 59.746 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 24.760 | 94.755 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 34.986 | 69.995 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 35.009 | 35.009 | ||||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -279.942 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -395.557 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -395.814 | 0 | |||||
| 2022-02-10 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Common Stock | I | 94.755 | 94.755 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Skalnyi Evgueni V. | UTRS | Common Stock | D | 20.250 | 194.970 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Jung Joel R | UTRS | Common Stock | D | 24.500 | 160.532 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Filloux Dominique J. | UTRS | Common Stock | D | 24.500 | 206.091 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Clapper David M | UTRS | Common Stock | D | 93.500 | 93.500 | ||||||
| 2021-12-15 | 2021-12-13 | 4 | Clapper David M | UTRS | Common Stock | I | 4,9374 | 25.000 | 123 | 642.660 | ||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -464 | 0 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -432 | 464 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -438 | 896 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -455 | 1.334 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -73.816 | 0 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -68.634 | 73.816 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -69.613 | 142.450 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -72.374 | 212.063 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 464 | 1.789 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 432 | 1.325 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 438 | 893 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 455 | 455 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 73.816 | 284.437 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 68.634 | 210.621 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 69.613 | 141.987 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 72.374 | 72.374 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -5.257 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -4.888 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -4.958 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -5.155 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -834.568 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -775.986 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -787.050 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -818.269 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Common Stock | I | 1.789 | 1.789 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Common Stock | I | 284.437 | 284.437 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -24.760 | 0 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -34.986 | 24.760 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -35.009 | 59.746 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 24.760 | 94.755 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 34.986 | 69.995 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 35.009 | 35.009 | ||||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -279.942 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -395.557 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | -395.814 | 0 | |||||
| 2021-12-08 | 2021-10-26 | 4/A | JAFFE ROSS A MD | UTRS | Common Stock | I | 94.755 | 94.755 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series D Preferred Stock | D | -3.503.021 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series D Preferred Stock | D | 850.491 | 3.503.021 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series D Preferred Stock | D | 546.011 | 2.652.530 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series D Preferred Stock | D | 503.145 | 2.106.519 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series D Preferred Stock | D | 517.592 | 1.603.374 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series D Preferred Stock | D | 532.333 | 1.085.782 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series D Preferred Stock | D | 553.449 | 553.449 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series D Preferred Stock | D | -3.409.709 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series C Preferred Stock | D | -1.190.212 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Series B Preferred Stock | D | -596.183 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Common Stock | D | 12,0000 | 1.300.000 | 15.600 | 9.999.125 | ||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Common Stock | D | 3.503.021 | 8.699.125 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Common Stock | D | 3.409.709 | 5.196.104 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Common Stock | D | 1.190.212 | 1.786.395 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | NEW ENTERPRISE ASSOCIATES 13 LP | UTRS | Common Stock | D | 596.183 | 596.183 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series D Preferred Stock | D | -3.306 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series D Preferred Stock | D | 742 | 3.306 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series D Preferred Stock | D | 480 | 2.564 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series D Preferred Stock | D | 501 | 2.084 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series D Preferred Stock | D | 516 | 1.583 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series D Preferred Stock | D | 523 | 1.067 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series D Preferred Stock | D | 544 | 544 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Subordinated Secured Convertible Promissory Note | D | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series D Preferred Stock | D | -4.196 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series C Preferred Stock | D | -704 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Series B Preferred Stock | D | -281 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Common Stock | D | 3.306 | 8.487 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Common Stock | D | 4.196 | 5.181 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Common Stock | D | 704 | 985 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | Behbahani Ali | UTRS | Common Stock | D | 281 | 281 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -24.760 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -34.986 | 24.760 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | -35.009 | 59.746 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 24.760 | 94.755 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 34.986 | 69.995 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Series D Preferred Stock | I | 35.009 | 35.009 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Subordinated Secured Convertible Promissory Note | I | 11,31 | 0 | ||||||
| 2021-10-28 | 2021-10-26 | 4 | JAFFE ROSS A MD | UTRS | Common Stock | I | 94.755 | 94.755 | ||||||
| 2021-10-27 | 2021-10-26 | 4 | Novo A/S | UTRS | SUBORDINATED SECURED CONVERTIBLE PROMISSORY NOTES | D | 0 | |||||||
| 2021-10-27 | 2021-10-26 | 4 | Novo A/S | UTRS | SERIES D REDEEMABLE CONVERTIBLE PREFERRED STOCK | D | -884.484 | 0 | ||||||
| 2021-10-27 | 2021-10-26 | 4 | Novo A/S | UTRS | COMMON STOCK | D | 12,0000 | 580.000 | 6.960 | 2.057.132 | ||||
| 2021-10-27 | 2021-10-26 | 4 | Novo A/S | UTRS | COMMON STOCK | D | 592.648 | 1.477.132 | ||||||
| 2021-10-27 | 2021-10-26 | 4 | Novo A/S | UTRS | COMMON STOCK | D | 884.484 | 884.484 | ||||||
| 2021-10-21 | 3 | Jung Joel R | UTRS | Common Stock | D | 136.032 | ||||||||
| 2021-10-21 | 3 | Skalnyi Evgueni V. | UTRS | Common Stock | D | 174.720 | ||||||||
| 2021-10-21 | 3 | Filloux Dominique J. | UTRS | Common Stock | D | 181.591 | ||||||||
| 2021-10-21 | 3 | Coste Catherine | UTRS | Common Stock | D | 79.787 | ||||||||
| 2021-10-21 | 3 | Clapper David M | UTRS | Common Stock | I | 617.660 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
